FDA advisory panel rejects widespread Pfizer booster shots
The surprising vote by the committee of outside experts assembled by the Food and Drug Administration was a 16-2, with members expressing frustration that Pfizer had provided littl…
The surprising vote by the committee of outside experts assembled by the Food and Drug Administration was a 16-2, with members expressing frustration that Pfizer had provided littl…